Understanding the mechanisms of nanomedicine absorption from the lungs and the application of this knowledge to improving the delivery of chemotherapeutic nanomedicines towards primary and secondary lung cancers

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1022732]

Researchers: Dr Lisa Kaminskas (Principal investigator)

Brief description The administration of chemotherapeutic 'nanomedicines' via the lungs has the capacity to improve the specific delivery of toxic anti-cancer drugs specifically towards primary and metastatic lung cancers. This project aims to evaluate how nanomedicines are absorbed from the lungs after an inhaled dose, and how they can be best developed as inhaled chemotherapeutics for the treatment of lung cancers.

Funding Amount $AUD 408,388.01

Funding Scheme Career Development Fellowships

Notes RD Wright Biomedical CDF

Subjects

Identifiers

nhmrc : 1022732
PURL : https://purl.org/au-research/grants/nhmrc/1022732

Understanding the mechanisms of nanomedicine absorption from the lungs and the application of this knowledge to improving the delivery of chemotherapeutic nanomedicines towards primary and secondary lung cancers [ 2012 - 2015 ]

Research Grant

Quick Links

Explore

External Resources

Share

Understanding the mechanisms of nanomedicine absorption from the lungs and the application of this knowledge to improving the delivery of chemotherapeutic nanomedicines towards primary and secondary lung cancers [ 2012 - 2015 ]

Research Grant

Related Organisations

Related People